RNS Number : 5815A
Dr. Martens PLC
15 April 2026
Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
The Company announces that it was notified on 15 April 2026 of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs') under the Company's Share Incentive Plan ('SIP').
The SIP is an HMRC approved, all-employee scheme under which participating employees are able to purchase shares in the Company from monthly salary ('Partnership Shares') and receive allocations of free 'Matching Shares', awarded at a rate of one Matching Share for every one Partnership Share purchased by a participating employee, from the Company.
On 14 April 2026, the following directors / PDMRs acquired Partnership Shares as a result of their participation in the SIP at a price of 64.70 pence per share and were granted an allocation of Matching Shares (for no consideration) in the quantity set out in the table below:
Director / PDMR
Number of Partnership Shares purchased
Number of Matching Shares awarded
Ije Nwokorie
232
232
Giles Wilson
232
232
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Ije Nwokorie
2
Reason for the notification
a)
Position/status
PDMR (Chief Executive Officer)
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Dr. Martens plc
b)
LEI
213800QPT8YM6NQZPH28
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument Identification code
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24
b)
Nature of the transaction
1. Purchase of Partnership Shares under the SIP 2. Award of Matching Shares under the SIP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1.
64.70p
232
2.
Nil
232
d)
Aggregated information
-
Aggregated volume
-
Price
-
Aggregated volume
-
Price
1.
Partnership shares
232
64.70p
2.
Matching shares
232
Nil
e)
Date of the transaction
14 April 2026
f)
Place of the transaction
1. London Stock Exchange (XLON) 2. Outside of a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Giles Wilson
2
Reason for the notification
a)
Position/status
PDMR (Chief Financial Officer)
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Dr. Martens plc
b)
LEI
213800QPT8YM6NQZPH28
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument Identification code
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24
b)
Nature of the transaction
1. Purchase of Partnership Shares under the SIP 2. Award of Matching Shares under the SIP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1.
64.70p
232
2.
Nil
232
d)
Aggregated information
-
Aggregated volume
-
Price
-
Aggregated volume
-
Price
1.
Partnership shares
232
64.70p
2.
Matching shares
232
Nil
e)
Date of the transaction
14 April 2026
f)
Place of the transaction
1. London Stock Exchange (XLON) 2. Outside of a trading venue
For further information please contact:
Zhwan Woof
Company Secretarial Assistant
+44(0)7585 3982165
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUVSWRNWUSARR
